BMS-790052, A FIRST-IN CLASS POTENT HEPATITIS C VIRUS NS5A INHIBITOR, DEMONSTRATES MULTIPLE-DOSE PROOF-OF-CONCEPT IN SUBJECTS WITH CHRONIC GT1 HCV INFECTIONRichard Nettles,Heather Sevinsky,Ellen Chung,David Burt,Hong Xiao,Thomas C. Marbury,R. Goldwater,Michael P. DeMicco,Maribel Rodriguez-Torres,Ernesto Fuentes,Apinya Bee Vutikullird,Eric Lawitz,A. Persson,Marc Bifano,Dennis M. GraselaHEPATOLOGY（2010）引用 0|浏览8暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
